KALA BIO, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
KALA BIO, INC. (KALA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $1.84 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2019-03-12
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-09-30 was $623.00K.
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-06-30 was $1.19M, a 2421.28% increase year-over-year.
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2017-03-31 was $36.00K.
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2017 was $1.84M.
- KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2016 was -$122.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $623.00K derived: sum of 2 quarters · filed 2019-03-12 | $1.81M derived: sum of 3 quarters · filed 2019-03-12 | $1.84M 10-K · filed 2019-03-12 |
| 2017-09-30 | $623.00K 10-Q · filed 2018-11-08 | $1.81M derived: sum of 2 quarters · filed 2018-11-08 | $1.84M 10-Q · filed 2018-11-08 | $1.90M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $1.19M 10-Q · filed 2018-08-09 | $1.22M 10-Q · filed 2018-08-09 | $1.28M derived: sum of 3 quarters · filed 2018-08-09 | $1.07M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $36.00K 10-Q · filed 2018-05-10 | $91.00K derived: sum of 2 quarters · filed 2018-05-10 | -$115.00K derived: sum of 3 quarters · filed 2018-05-10 | -$68.00K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$151.00K derived: sum of 2 quarters · filed 2018-04-02 | -$104.00K derived: sum of 3 quarters · filed 2018-04-02 | -$122.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | -$206.00K 10-Q · filed 2017-11-07 | -$159.00K derived: sum of 2 quarters · filed 2017-11-07 | -$177.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $47.00K 10-Q · filed 2017-08-31 | $29.00K 10-Q · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |